Progress Against Pain
This article was originally published in Start Up
Executive Summary
Morphine and other opiates are still the most effective treatments for severe pain, but patients and clinicians alike are leery of their addictive properties. Consequently, experts say some 50% of chronic pain sufferers are undertreated. Recent scientific insights into the physiology and anatomy of pain are inspiring a host of corporate efforts to create new and improved medications.
You may also be interested in...
New Drugs for Pain
Spectacular failures in stroke and neurodegenerative diseases have given drug developers a black eye, but along the way, the insights they've gleaned in neurobiology have revealed new targets for pain. Unfortunately, the targets keep moving.
Super-Specialist CROs: Commercializing Pharma R&D Expertise
Outsourcing is not just for mundane pharma services anymore. Increasingly, drugmakers are contracting for specialized R&D assistance they expect to provide strategic as well as tactical advantages.
Spero Therapeutics: Remodeling Antibiotics
Like other companies investigating entirely new ways of treating bacterial infections, biotech start-up Spero is increasingly aware that novel antibiotics may need to travel new clinical and regulatory pathways to market.